Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

15.01 -0.55 (-3.53%)

Streaming Delayed Price Updated: 12:31 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

35 36 Next >

SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 18, 2025

From Schall Law

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 18, 2025

Via Benzinga

Sarepta Therapeutics Stock Plunges Over 30% In Friday Pre-Market: What's Going On ↗

July 18, 2025

Shares of Sarepta Therapeutics (NASDAQ: SRPT) plunged 26.85% in Friday pre-market after a clinical trial participant died following treatment with a gene therapy, marking the third death linked to the...

Via Benzinga

Topics Death

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2025

Via Benzinga

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

July 17, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Sarepta Therapeutics' Reorganization Boosts Investor Confidence ↗

July 17, 2025

Sarepta agrees to FDA's black box warning and announces major restructuring, including job cuts and cost-saving measures to meet 2027 goals.

Via Benzinga

AAR, Lucid Group, Monarch Casino & Resort And Other Big Stocks Moving Higher On Thursday ↗

July 17, 2025

Via Benzinga

Assessing Sarepta Therapeutics: Insights From 35 Financial Analysts ↗

July 17, 2025

Via Benzinga

Investors in Sarepta Therapeutics, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT

July 17, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Investors in Sarepta Therapeutics, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights - SRPT

July 17, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

What's going on in today's pre-market session ↗

July 17, 2025

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 17, 2025

Via Benzinga

Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2025

Via Benzinga

Sarepta To Lay Off 500 Employees After Two Patient Deaths; Shares Catapult ↗

July 16, 2025

The company is also restructuring with the hopes of saving $400 million in expenses.

Via Investor's Business Daily

Topics Death Earnings Government

Sarepta Surges After-Hours As It Slashes 500 Jobs Amid FDA Black Box Warning For Gene Therapy — Retail Eyes Rebound ↗

July 16, 2025

The company also updated investors on its ELEVIDYS gene therapy label, agreed to an FDA-requested black box warning, and outlined plans to resume dosing in non-ambulant patients.

Via Stocktwits

Topics Death

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm

July 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 16, 2025

Via Benzinga

Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On? ↗

July 16, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

July 16, 2025

The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label

July 16, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SRPT

July 16, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Sarepta Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SRPT

July 16, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics

July 16, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)

July 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Sarepta Therapeutics, Inc. (SRPT)

July 15, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT

July 14, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

SAREPTA THERAPEUTICS, INC. (NASDAQ: SRPT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Sarepta Therapeutics, Inc. Investors of Upcoming Deadline

July 14, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders

July 14, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders

July 14, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

All News about Sarepta Therapeutics, Inc. - Common Stock